About this trial
The purpose of this study is to assess whether introducing table olives into the diet results in health-related benefits for young adults. Several studies have shown that addition of olives as part of somebody's diet has a positive impact on cardiovascular, metabolic, and inflammatory factors. However, there have not been many studies among young, healthy adults. This study will compare levels of specific biomarkers, collected through blood draw, at the beginning of the study and after 5 weeks, to evaluate the effects of investigational daily olive consumption.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Yale College Freshman, Sophomore, or Junior
Ability and desire to sign informed consent
Stated willingness to comply with all study procedures and availability for the duration of the study
Male or female, age 18 on the day of consent
Disqualifiers
Yale College Senior
Unable to provide informed consent form
Self-reported pregnancy
Unwillingness to comply with all study procedures and/or be available for the duration of the study
Trial design
Parallel
Treatments tested in this trial
Olives
Dietary supplementOrganic olives (provided by Sakellaropoulos Organic Farms; Sparta, Greece)
Treatment groups
Trial outcomes
Primary outcomes
Change From Baseline in Mean LDL at Week 5
Blood draw to assess LDL at baseline and week five. Change will be calculated by comparing means of the differences (5 weeks-Baseline) between the two study groups, a decrease in the mean from baseline is positive.
Compliance/adherence to daily intervention
Assessment and verification of receipt of the olives will be tied to the dining hall card swipe that is part of the student's access to the dining facility, for study participants in the olives group. Swipe=adherent.
Secondary outcomes
Change From Baseline in Mean HDL at Week 5
Blood draw to assess HDL at baseline and week five. Change will be calculated by comparing means of the differences (5 weeks-Baseline) between the two study groups, a decrease in the mean from baseline is positive.
Change From Baseline in Mean LDL/HDL at Week 5
Blood draw to assess LDL/HDL ratio at baseline and week five. Change will be calculated by comparing means of the differences (5 weeks-Baseline) between the two study groups, a decrease in the mean from baseline is positive.
Change From Baseline in Mean HbA1c at Week 5
Blood draw to assess HbA1C at baseline and week five. Change will be calculated by comparing means of the differences (5 weeks-Baseline) between the two study groups, a decrease in the mean from baseline is positive.
Change From Baseline in Mean CRP at Week 5
Blood draw to assess CRP at baseline and week five. Change will be calculated by comparing means of the differences (5 weeks-Baseline) between the two study groups, a decrease in the mean from baseline is positive.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: